125 related articles for article (PubMed ID: 29086002)
1. CTNNB1-mutated melanocytic lesions with DPN like features: a distinct subtype of melanocytic tumors? A report of two cases.
Teunissen BT; Knuiman GJ; Eijkelenboom A; Wauters CAP; Wouda S; Blokx WAM
Virchows Arch; 2018 Apr; 472(4):683-687. PubMed ID: 29086002
[No Abstract] [Full Text] [Related]
2. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
[TBL] [Abstract][Full Text] [Related]
3. β-Catenin nuclear expression discriminates deep penetrating nevi from other cutaneous melanocytic tumors.
de la Fouchardière A; Caillot C; Jacquemus J; Durieux E; Houlier A; Haddad V; Pissaloux D
Virchows Arch; 2019 May; 474(5):539-550. PubMed ID: 30756182
[TBL] [Abstract][Full Text] [Related]
4. Malignant melanoma arising from an NRAS-mutated medium-sized congenital melanocytic nevus.
Kiyohara T; Takata M; Itoh H; Kawami K; Ido H; Ishida H; Kumakiri M
J Dermatol; 2012 Dec; 39(12):1034-5. PubMed ID: 22452623
[No Abstract] [Full Text] [Related]
5. [Cutaneous melanocytic tumors. Case 2].
Castillo C
Ann Pathol; 2016 Oct; 36(5):322-325. PubMed ID: 27639774
[No Abstract] [Full Text] [Related]
6. BAP1 deficient malignant melanoma arising from the intradermal component of a congenital melanocytic naevus.
Ardakani NM; Palmer DL; Wood BA
Pathology; 2015 Dec; 47(7):707-10. PubMed ID: 26517632
[No Abstract] [Full Text] [Related]
7. Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesions.
Cesinaro AM; Natoli C; Grassadonia A; Tinari N; Iacobelli S; Trentini GP
J Invest Dermatol; 2002 Jul; 119(1):187-90. PubMed ID: 12164944
[No Abstract] [Full Text] [Related]
8. Melanocytic lesions, Spitz tumors, and Don Ferrante's logic.
Urso C
Am J Dermatopathol; 2007 Oct; 29(5):491-4. PubMed ID: 17890925
[No Abstract] [Full Text] [Related]
9. Dermoscopy of melanocytic neoplasms: familial patterns.
Grichnik JM
Arch Dermatol; 2004 May; 140(5):642. PubMed ID: 15148119
[No Abstract] [Full Text] [Related]
10. Primary cutaneous melanoma arising in agminated melanocytic nevi: CDKN2A and CDK4 mutation screening.
Rezze GG; Leon A; Silva DC; Neves RI; Molina GC; Carraro DM; Landman G; Duprat JP
Acta Derm Venereol; 2012 Jan; 92(1):98-9. PubMed ID: 21710107
[No Abstract] [Full Text] [Related]
11. Towards diagnostic criteria for malignant deep penetrating melanocytic tumors using single nucleotide polymorphism array and next-generation sequencing.
Ebbelaar CF; Schrader AMR; van Dijk M; Meijers RWJ; de Leng WWJ; Bloem LT; Jansen AML; Blokx WAM;
Mod Pathol; 2022 Aug; 35(8):1110-1120. PubMed ID: 35184152
[TBL] [Abstract][Full Text] [Related]
12. Combination of Congenital and Deep Penetrating Nevus by Acquisition of β-Catenin Activation.
Garrido MC; Nájera L; Navarro A; Huerta V; Garrido E; Rodriguez-Peralto JL; Requena L
Am J Dermatopathol; 2020 Dec; 42(12):948-952. PubMed ID: 32568834
[TBL] [Abstract][Full Text] [Related]
13. Melanocytic nevi clinically simulating melanoma.
Makino E; Uchida T; Matsushita Y; Inaoki M; Fujimoto W
J Dermatol; 2007 Jan; 34(1):52-5. PubMed ID: 17204102
[TBL] [Abstract][Full Text] [Related]
14. Melanocytic nevi and tumor progression: perspectives concerning histomorphology, melanoma risk and molecular genetics.
Barnhill RL
Dermatology; 1993; 187(2):86-90. PubMed ID: 8358111
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.
de Jel MM; Engelmann JC; Kunz M; Schiffner S; Kuphal S; Bosserhoff AK
Pigment Cell Melanoma Res; 2014 Jul; 27(4):678-80. PubMed ID: 24661573
[No Abstract] [Full Text] [Related]
16. Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'.
Clark WH; Reimer RR; Greene M; Ainsworth AM; Mastrangelo MJ
Arch Dermatol; 1978 May; 114(5):732-8. PubMed ID: 646394
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic and mutational analyses of melanocytic tumors.
Gerami P; Busam KJ
Dermatol Clin; 2012 Oct; 30(4):555-66, v. PubMed ID: 23021045
[TBL] [Abstract][Full Text] [Related]
18. The effect of the sun on expression of beta-catenin, p16 and cyclin d1 proteins in melanocytic lesions.
Demirkan NC; Kesen Z; Akdag B; Larue L; Delmas V
Clin Exp Dermatol; 2007 Nov; 32(6):733-9. PubMed ID: 17868395
[TBL] [Abstract][Full Text] [Related]
19. Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree.
Florell SR; Meyer LJ; Boucher KM; Grossman D; Cannon-Albright LA; Harris RM; Samlowski WE; Zone JJ; Leachman SA
J Invest Dermatol; 2008 Aug; 128(8):2122-5. PubMed ID: 18337833
[No Abstract] [Full Text] [Related]
20. Recurrent pigmented melanocytic nevus. A benign lesion, not to be mistaken for malignant melanoma.
Sexton M; Sexton CW
Arch Pathol Lab Med; 1991 Feb; 115(2):122-6. PubMed ID: 1992976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
